
zzso combination therapy has been the standard empirical approach for zzso zzso cancer zzso With the advent of the zzso oral zzso it is now possible to evaluate an initial empirical alternative zzso A prospective zzso study was conducted comparing oral zzso plus zzso V zzso zzso with zzso plus zzso or zzso zzso zzso Main criteria for eligibility were zzso patients with solid tumor or zzso lymphoma, a zzso zzso equal to 1 or 2, no zzso zzso or long-term central zzso zzso A total of 108 consecutive zzso zzso episodes were zzso (5 zzso 55 episodes were assigned to group A and 48 to group zzso Most zzso episodes were of unknown zzso There were 10 zzso documented episodes with two cases of zzso Both regimens were well zzso zzso regimen was substantially cheaper than zzso zzso Treatment success without regimen modification was zzso for group A and zzso for group B zzso zzso zzso zzso zzso zzso therapy with zzso and zzso V is a safe alternative to standard zzso therapy in this low-risk group of zzso patients, with zzso cost zzso 

